Overview Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017) Status: Completed Trial end date: 2003-05-01 Target enrollment: Participant gender: Summary Efficacy and Safety Study of MK0359 in Patients with Arthritis Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.